SOGUG-AVELUMAB_RWD

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

September 5, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

November 2, 2023

Conditions
Metastatic Urothelial Carcinoma
Interventions
DRUG

Avelumab

Single Group Assignment

Trial Locations (22)

Unknown

Complexo Hospitalario Universitario de Vigo, Vigo

Complexo Hospitalario Universitario A Coruña, A Coruña

Complejo Hospitalario Universitario Albacete, Albacete

Complejo Hospitalario Torrecárdenas, Almería

Hospital Universitario Basurto, Bilbao

Hospital Universitario de Burgos, Burgos

Hospital Provincial de Castellón, Castellon

Hospital Universitario Vinalopó, Elche

Hospital General Universitario de Elda, Elda

Hospital Universitario de Guadalajara, Guadalajara

Hospital Clínico Universitario San Carlos, Madrid

Hospital Universitario Ramón y Cajal, Madrid

Hospital Universitario Virgen de la Arrixaca, Murcia

Complexo Hospitalario Universitario Ourense, Ourense

Hospital Universitario Central de Asturias, Oviedo

Hospital Río Carrión, Palencia

Hospital Sagunto, Sagunto

Hospital Universitario de Salamanca, Salamanca

Complexo Hospitalario Universitario Santiago, Santiago de Compostela

Fundación Instituto Valenciano de Oncología, Valencia

Hospital Universitario Politècnic La Fe, Valencia

Hospital Marina Baixa Villajosyosa, Villajoyosa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Adknoma Health Research

INDUSTRY

lead

Spanish Oncology Genito-Urinary Group

OTHER

NCT05700344 - SOGUG-AVELUMAB_RWD | Biotech Hunter | Biotech Hunter